Jump to main content
Jump to site search

Issue 12, 2009
Previous Article Next Article

Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis

Author affiliations

Abstract

Many eukaryotic and prokaryotic proteins remain disordered under physiological conditions and often acquire a stable secondary structure on binding to their cellular targets. Though the process of binding is still under analysis, it has been found that the flexibility of proteins can add to their functionality. This motivated us to explore intrinsically disordered proteins (IDPs) as drug targets. In silico studies have been carried out on Mycobacterium tuberculosis, which, with emergence of hyper-virulent and drug resistant strains, XDRs and MDRs, is one of the most dreaded pathogens in the modern world. Our study reports 13 IDPs as potential drug targets, and three of them—FtsW (Rv2154c), GlmU (Rv1018c) and Obg (Rv2440c)—are chosen as key proteins and are described in detail. Future applications of this method can provide new insight into understanding the molecular mechanism of IDPs and their potential role as drug targets.

Graphical abstract: Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis

Back to tab navigation

Supplementary files

Article information


Submitted
18 Mar 2009
Accepted
18 May 2009
First published
15 Jul 2009

Mol. BioSyst., 2009,5, 1752-1757
Article type
Paper

Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis

M. Anurag and D. Dash, Mol. BioSyst., 2009, 5, 1752
DOI: 10.1039/B905518P

Search articles by author

Spotlight

Advertisements